Skip Navigation

Providing Patients Hope With Right to Try (Guest: Bartley Madden)

June 5, 2018

Bartley Madden, author of Free to Choose Medicine, discusses the recent signing by President Donald Trump of Right to Try legislation and the general move towards Free to Choose Medicine.

Recently, President Donald Trump signed Right to Try legislation, codifying the policy idea that terminal patients and their families should be given the freedom to decide what treatments, therapies, and drugs they're comfortable trying without waiting for the arduous approval process of the Food and Drug Administration.

Madden, a longtime proponent of Right to Try, talks about the issue as it relates to the broader effort, supported by The Heartland Institute, of giving Americans freedom to choose their health care drugs and therapies after those drugs and therapies have passed the safety, and a portion of the efficacy, phases of the FDA approval process. Madden credits Heartland President Tim Huelskamp and other libertarian and conservative-leaning organizations and individuals for bringing the issue to the attention of the Trump administration and discusses his optimism that Wednesday's signing marks the first step in the long process toward freedom of choice in health care.

Article Tags
Health Care
Author
Sarah Lee is the managing editor of Health Care News and a research fellow at The Heartland Institute.
slee@heartland.org @HCPolicy
Author
Bartley J. Madden retired as a managing director of Credit Suisse HOLT after a career in investment research and money management that included the founding of Callard Madden & Associates.
bartmadden@yahoo.com